Investigation of Sequential Growth Factor Delivery during Cuprizone Challenge in Mice Aimed to Enhance Oligodendrogliogenesis and Myelin Repair

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Sabo, Jennifer K ^a   Aumann, Tim D ^a   Kilpatrick, Trevor J ^a   Cate, Holly S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CUPRIZONE; NOGGIN; SOMATOMEDIN C; BMP4 PROTEIN, HUMAN; CARRIER PROTEIN; NOGGIN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; MOUSE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; REMYELINIZATION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CHEMICALLY INDUCED; DEMYELINATING DISEASES; DRUG COMBINATION; DRUG EFFECTS; DRUG SCREENING; MYELIN SHEATH; PATHOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; ASTROCYTES; BONE MORPHOGENETIC PROTEIN 4; CARRIER PROTEINS; CELL DIFFERENTIATION; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C57BL; MYELIN SHEATH; NEURAL STEM CELLS; OLIGODENDROGLIA;

EID: 84877076020     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063415     Document Type: Article

References (34)

1. Nave KA, Trapp BD, (2008) Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31: 535-561.
2. Barnett MH, Prineas JW, (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55: 458-468.
3. Franklin RJ, Ffrench-Constant C, (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9: 839-855.
4. Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC, (2002) Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 22: 8574-8585.
5. Mason JL, Xuan S, Dragatsis I, Efstratiadis A, Goldman JE, (2003) Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J Neurosci 23: 7710-7718.
6. Aguirre A, Dupree JL, Mangin JM, Gallo V, (2007) A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci 10: 990-1002.
7. VonDran MW, Singh H, Honeywell JZ, Dreyfus CF, (2011) Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion. J Neurosci 31: 14182-14190.
8. Sabo JK, Aumann TD, Merlo D, Kilpatrick TJ, Cate HS, (2011) Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions. J Neurosci 31: 4504-4510.
9. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, et al. (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70: 31-46.
10. Pang Y, Zheng B, Fan LW, Rhodes PG, Cai Z, (2007) IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway. Glia 55: 1099-1107.
11. Carson MJ, Behringer RR, Brinster RL, McMorris FA, (1993) Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10: 729-740.
12. Ye P, Carson J, D'Ercole AJ, (1995) In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci 15: 7344-7356.
13. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F, (1995) Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14: 717-730.
14. Mason JL, Ye P, Suzuki K, D'Ercole AJ, Matsushima GK, (2000) Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 20: 5703-5708.
15. Cate HS, Sabo JK, Merlo D, Kemper D, Aumann TD, et al. (2010) Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination. J Neurochem 115: 11-22.
16. Binder MD, Cate HS, Prieto AL, Kemper D, Butzkueven H, et al. (2008) Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination. J Neurosci 28: 5195-5206.
17. Song K, Rao NJ, Chen ML, Huang ZJ, Cao YG, (2011) Enhanced bone regeneration with sequential delivery of basic fibroblast growth factor and sonic hedgehog. Injury 42: 796-802.
18. Zhu S, Lee DA, Li S, (2010) IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. J Immunol 184: 2348-2354.
19. Ruvinov E, Leor J, Cohen S, (2011) The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 32: 565-578.
20. Tengood JE, Ridenour R, Brodsky R, Russell AJ, Little SR, (2011) Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis. Tissue Eng Part A 17: 1181-1189.
21. Dummula K, Vinukonda G, Chu P, Xing Y, Hu F, et al. (2011) Bone morphogenetic protein inhibition promotes neurological recovery after intraventricular hemorrhage. J Neurosci 31: 12068-12082.
22. Hsieh J, Aimone JB, Kaspar BK, Kuwabara T, Nakashima K, et al. (2004) IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes. J Cell Biol 164: 111-122.
23. Wahdan-Alaswad RS, Song K, Krebs TL, Shola DT, Gomez JA, et al. (2010) Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling. Cancer Res 70: 9106-9117.
24. Samanta J, Kessler JA, (2004) Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131: 4131-4142.
25. Firth SM, Baxter RC, (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824-854.
26. Kuhl NM, De Keyser J, De Vries H, Hoekstra D, (2002) Insulin-like growth factor binding proteins-1 and-2 differentially inhibit rat oligodendrocyte precursor cell survival and differentiation in vitro. J Neurosci Res 69: 207-216.
27. Peters I, Tossidou I, Achenbach J, Woroniecki R, Mengel M, et al. (2006) IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes. J Am Soc Nephrol 17: 1644-1656.
28. Mukherjee A, Rotwein P, (2008) Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions. Mol Endocrinol 22: 1238-1250.
29. Yao DL, Liu X, Hudson LD, Webster HD, (1995) Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 92: 6190-6194.
30. Cannella B, Pitt D, Capello E, Raine CS, (2000) Insulin-like growth factor-1 fails to enhance central nervous system myelin repair during autoimmune demyelination. Am J Pathol 157: 933-943.
31. Genoud S, Maricic I, Kumar V, Gage FH, (2005) Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis. J Neuroimmunol 168: 40-45.
32. O'Leary MT, Hinks GL, Charlton HM, Franklin RJ, (2002) Increasing local levels of IGF-I mRNA expression using adenoviral vectors does not alter oligodendrocyte remyelination in the CNS of aged rats. Mol Cell Neurosci 19: 32-42.
33. Frank JA, Richert N, Lewis B, Bash C, Howard T, et al. (2002) A pilot study of recombinant insulin-like growth factor-1 in seven multiple sderosis patients. Mult Scler 8: 24-29.
34. Keirstead HS, Blakemore WF, (1997) Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J Neuropathol Exp Neurol 56: 1191-1201.